Furthermore, the activation of hepatic CB1R was observed in insulin resistance, impaired metabolic function, and obesity, either by the upsurge of energy intake, glucose impairment, lipid metabolism, or increased reactive oxygen species and cytokines release (3, 7–9). The gene discussed is CNR1; the disease is Obesity.